TrialThe Journal of asthma : official journal of the Association for the Care of Asthma2016

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.

Gordon Raphael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.